Quantitative Oculomotor and Vestibular Profile in Spinocerebellar Ataxia Type 6 - Systematic Review and Meta-Analysis.
Tarnutzer AA. et al, (2024), Cerebellum, 24
Accelerating Parkinson's Disease drug development with federated learning approaches.
Khanna A. et al, (2024), NPJ Parkinsons Dis, 10
Defining an ageing-related pathology, disease or syndrome: International Consensus Statement.
Short E. et al, (2024), Geroscience
Retinal morphological differences in atypical Parkinsonism: A cross-sectional analysis of the AlzEye cohort
Patel S. et al, (2024), Biomarkers in Neuropsychiatry, 10
Differential effects of bilateral hippocampal CA3 damage on the implicit learning and recognition of complex event sequences.
Miller TD. et al, (2024), Cogn Neurosci, 1 - 29
A novel machine learning based framework for developing composite digital biomarkers of disease progression.
Zhai S. et al, (2024), Front Digit Health, 6
Eye movements in Parkinson's disease: from neurophysiological mechanisms to diagnostic tools
ANTONIADES C., (2023), Trends in Neurosciences
Using Smartphone Sensors for Ataxia Trials: Consensus Guidance by the Ataxia Global Initiative Working Group on Digital-Motor Biomarkers
ANTONIADES C., (2023), The Cerebellum: an international journal from neurosciences to clinical perspectives
Retinal Optical Coherence Tomography Features Associated With Incident and Prevalent Parkinson Disease.
Wagner SK. et al, (2023), Neurology, 101, e1581 - e1593
Identification of motor progression in Parkinson’s disease using wearable sensors and machine learning
Sotirakis C. et al, (2023), npj Parkinson's Disease, 9
Antiparkinsonian medication masks motor signal progression in de novo patients
Brzezicki MA. et al, (2023), Heliyon, 9, e16415 - e16415
Longitudinal monitoring of Progressive Supranuclear Palsy using Body-Worn movement sensors
ANTONIADES C. and FITZGERALD J., (2022), MDS
Oculomotor deficits in Parkinson's disease: Increasing sensitivity using multivariate approaches
Bredemeyer O. et al, (2022), Frontiers in Digital Health, 4
Deep Brain Stimulation and Levodopa Affect Gait Variability in Parkinson Disease Differently
Su ZH. et al, (2022), Neuromodulation: Technology at the Neural Interface